Vascepa is a prescription medication used to reduce the risk of heart attack, stroke, and other cardiovascular diseases. According to the official website of Vascepa, the Vascepa Savings Program is available to eligible patients who have commercial insurance and pay cash for their prescriptions. The program offers savings for eligible patients on out-of-pocket costs for Vascepa, up to a maximum of $75 per prescription. To be eligible for the program, patients must meet certain criteria, including being a resident of the United States or Puerto Rico, having a valid prescription for Vascepa, and not being enrolled in any state or federally funded programs.

Additionally, the eligibility for the Vascepa discount may depend on the expiration of the drug's patent. According to Drug Patent Watch, the patent for Vascepa is set to expire in 2030, which means that after that date, generic versions of the medication may become available. However, the expiration of the patent does not necessarily affect the eligibility for the Vascepa Savings Program.

In summary, the Vascepa Savings Program is available to eligible patients who have commercial insurance and pay cash for their prescriptions. Patients must meet certain criteria, including being a resident of the United States or Puerto Rico, having a valid prescription for Vascepa, and not being enrolled in any state or federally funded programs. The expiration of the drug's patent does not affect the eligibility for the program.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.vascepa.com/getting-started/vascepa-savings/
[3] https://vascepa.copaysavingsprogram.com/